Clinical trial
Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the…
NCT00366132 · Tissue Regeneration Technologies, Industry · Unknown status
Key facts
| NCT number | NCT00366132 |
|---|---|
| Title | Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers |
| Official title | DermaGold Indicated for Use of Shockwave Treat of Diabetic Foot Ulcers in Patients With Diabetes Mellitus |
| Lead sponsor | Tissue Regeneration Technologies, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Diabetic Foot Ulcers |
| Intervention type | Device |
| Interventions | Extracorporeal Shockwaves |
| Enrollment | 200 |
| Start date | Mar 1, 2006 |
| First posted | Aug 18, 2006 |
| Last update posted | Aug 18, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: